CFM
TARS icon

Capricorn Fund Managers’s Tarsus Pharmaceuticals TARS Stock Holding History

Capricorn Fund Managers’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Buy
26,000
+4,018
+18% +$281K 0.28% 77
2025
Q4 		$1.8M Sell
21,982
-218,038
-91% -$16.3M 0.43% 58
2025
Q3 		$14.3M Buy
+240,020
New +$11.8M 4.79% 2

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capricorn Fund Managers's TARS Position: Q1 2026 in Review

Capricorn Fund Managers increased its Tarsus Pharmaceuticals (TARS) stake by 18% in Q1 2026, buying an estimated $281K and bringing the position to 26,000 shares worth $1.82M. The position accounts for 0.28% of the portfolio, ranked #77.

Capricorn Fund Managers first reported a position in TARS in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.3M in Q3 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Capricorn Fund Managers held 26,000 shares of Tarsus Pharmaceuticals worth $1.82M as of Q1 2026.
  • Capricorn Fund Managers bought 4,018 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $281K.
  • Tarsus Pharmaceuticals made up 0.28% of Capricorn Fund Managers's portfolio in Q1 2026, its #77 holding.
  • Capricorn Fund Managers first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Capricorn Fund Managers's Tarsus Pharmaceuticals position peaked at $14.3M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Capricorn Fund Managers's 13F filing for Q1 2026, filed 24 Apr 2026.